Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004524-21Phase 2Completed
Phase 2, randomised trial in pain and hyperalgesia comparing Buprenorphine transdermal, Fentanyl transdermal and Placebo transdermal (3 arms). Primary endpoints: Analgesic effect on experimental pain models and Anti-hyperalgesic effect on experimental pain models. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004524-21.